ATI Physical Therapy, Inc. (ATIP)
NYSE: ATIP · Real-Time Price · USD
1.590
-0.130 (-7.56%)
Nov 20, 2024, 4:00 PM EST - Market closed
ATI Physical Therapy Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ATIP.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ATIP.
Recommendation Trends
Rating | Jun '22 | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 1 | 1 | 2 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 3 | 3 | 3 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Deutsche Bank | Deutsche Bank | Hold Maintains $100 → $33 | Hold | Maintains | $100 → $33 | +1,944.03% | Nov 16, 2022 |
Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 10, 2022 |
Citigroup | Citigroup | Hold Maintains $70 → $60 | Hold | Maintains | $70 → $60 | +3,673.58% | Nov 8, 2022 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 27, 2022 |
Benchmark | Benchmark | Strong Buy Maintains $200 → $100 | Strong Buy | Maintains | $200 → $100 | +6,189.31% | Aug 10, 2022 |
Financial Forecast
Revenue This Year
760.15M
from 687.77M
Increased by 10.52%
Revenue Next Year
794.87M
from 760.15M
Increased by 4.57%
EPS This Year
-12.66
from -31.93
EPS Next Year
-9.63
from -12.66
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 785.5M | 834.3M |
Avg | 760.2M | 794.9M |
Low | 727.5M | 748.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 14.2% | 9.8% |
Avg | 10.5% | 4.6% |
Low | 5.8% | -1.5% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -13.03 | -7.96 |
Avg | -12.66 | -9.63 |
Low | -12.16 | -11.08 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.